Zhuhai Rundu Pharmaceutical Co Ltd Class A - Asset Resilience Ratio
Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. Check Zhuhai Rundu Pharmaceutical Co Ltd Class PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Zhuhai Rundu Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002923 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥56.72K | 0.0% |
| Total Liquid Assets | CN¥56.72K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Zhuhai Rundu Pharmaceutical Co Ltd Class A maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio
Compare Zhuhai Rundu Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621 |
Drug Manufacturers - Specialty & Generic | 2.04% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
|
Jw Pharmac
KO:001060 |
Drug Manufacturers - Specialty & Generic | 3.65% |
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Samjin Pharm
KO:005500 |
Drug Manufacturers - Specialty & Generic | 0.25% |
Annual Asset Resilience Ratio for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Zhuhai Rundu Pharmaceutical Co Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | CN¥65.71K ≈ $9.62K |
CN¥2.19 Billion ≈ $321.00 Million |
+0.00pp |
| 2023-12-31 | 0.00% | CN¥52.23K ≈ $7.64K |
CN¥2.23 Billion ≈ $325.99 Million |
0.00pp |
| 2022-12-31 | 0.00% | CN¥61.78K ≈ $9.04K |
CN¥2.29 Billion ≈ $334.56 Million |
0.00pp |
| 2021-12-31 | 0.00% | CN¥86.77K ≈ $12.70K |
CN¥1.91 Billion ≈ $279.41 Million |
-2.90pp |
| 2020-12-31 | 2.91% | CN¥44.01 Million ≈ $6.44 Million |
CN¥1.51 Billion ≈ $221.51 Million |
-- |
About Zhuhai Rundu Pharmaceutical Co Ltd Class A
Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, qu… Read more